Cargando…

Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction—A Pilot Study

Galectin-3 (Gal-3) is a new independent risk factor in the development and severity of coronary artery disease (CAD). The aim of the study was to evaluate whether Gal-3 concentration has prognostic value and if it reflects the progression of atherosclerosis in carotid arteries in patients with CAD a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Święcki, Przemysław, Sawicki, Robert, Knapp, Małgorzata, Kamiński, Karol Adam, Ptaszyńska-Kopczyńska, Katarzyna, Sobkowicz, Bożena, Lisowska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355423/ https://www.ncbi.nlm.nih.gov/pubmed/32485853 http://dx.doi.org/10.3390/jcm9061640

Ejemplares similares

ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value
por: Michalski, Tomasz Adam, et al.
Publicado: (2022)

IGFBP7 Concentration May Reflect Subclinical Myocardial Damage and Kidney Function in Patients with Stable Ischemic Heart Disease
por: Lisowska, Anna, et al.
Publicado: (2022)

Echocardiographic Assessment of Right Ventricular–Arterial Coupling in Predicting Prognosis of Pulmonary Arterial Hypertension Patients
por: Kazimierczyk, Remigiusz, et al.
Publicado: (2021)

Atrial Fibrillation in Patients with Acute Pulmonary Embolism: Clinical Significance and Impact on Prognosis
por: Ptaszynska-Kopczynska, Katarzyna, et al.
Publicado: (2019)

Monocyte Subsets in Patients with Chronic Heart Failure Treated with Cardiac Resynchronization Therapy
por: Ptaszyńska-Kopczyńska, Katarzyna, et al.
Publicado: (2021)

Machine-learning facilitates selection of a novel diagnostic panel of metabolites for the detection of heart failure
por: Marcinkiewicz-Siemion, M., et al.
Publicado: (2020)

Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study
por: Wojciuk, Mariusz, et al.
Publicado: (2021)

Paroxysmal Atrial Fibrillation in the Course of Acute Pulmonary Embolism: Clinical Significance and Impact on Prognosis
por: Krajewska, Agnieszka, et al.
Publicado: (2017)

A 39-Year-Old Woman with Ventricular Electrical Storm Treated with Emergency Cardiac Defibrillation Followed by Multidisciplinary Management
por: Sielatycki, Piotr, et al.
Publicado: (2022)

Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy
por: Ptaszynska-Kopczynska, Katarzyna, et al.
Publicado: (2016)

Insulin-Like Growth Factor-Binding Protein 7 (IGFBP-7)—New Diagnostic and Prognostic Marker in Symptomatic Peripheral Arterial Disease?—Pilot Study
por: Szyszkowska, Anna, et al.
Publicado: (2022)

Impact of Pulse Wave Velocity and Parameters Reflecting Android Type Fat Distribution on Left Ventricular Diastolic Dysfunction in Patients with Chronic Coronary Syndromes
por: Paniczko, Marlena, et al.
Publicado: (2020)

Galectin-1 in Early Acute Myocardial Infarction
por: Al-Salam, Suhail, et al.
Publicado: (2014)

Correlation between Galectin-3 and Adverse Outcomes in Myocardial Infarction Patients: A Meta-Analysis
por: Tian, Lei, et al.
Publicado: (2020)

ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals with Low Cardiovascular Risk
por: Chlabicz, Małgorzata, et al.
Publicado: (2020)

Labeling galectin-3 for the assessment of myocardial infarction in rats
por: Arias, Teresa, et al.
Publicado: (2014)

Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction
por: Tycinska, Agnieszka M., et al.
Publicado: (2011)

Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction
por: Gagno, Giulia, et al.
Publicado: (2019)

The rs2228145 polymorphism in the interleukin-6 receptor and its association with long-term prognosis after myocardial infarction in a pilot study
por: Szpakowicz, Anna, et al.
Publicado: (2016)

Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
por: Karetnikova, Victoria, et al.
Publicado: (2016)

Serum Vaspin as a Predictor of Adverse Cardiac Events in Acute Myocardial Infarction
por: Zhou, Xiang, et al.
Publicado: (2019)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Impaired Diastolic Recovery after Acute Myocardial Infarction as a Predictor of Adverse Events
por: Yoon, Hyun Ju, et al.
Publicado: (2015)

Value of ATRIA risk score and gender in predicting adverse events in patients with myocardial infarction
por: Öncel, Can Ramazan
Publicado: (2018)

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

Impact of Right Atrial Physiology on Heart Failure and Adverse Events after Myocardial Infarction
por: Schuster, Andreas, et al.
Publicado: (2020)

Disparities in the Prevalence and Risk Factors for Carotid and Lower Extremities Atherosclerosis in a General Population—Bialystok PLUS Study
por: Lisowska, Anna, et al.
Publicado: (2023)

Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
por: Pełech, Aleksandra, et al.
Publicado: (2023)

Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction
por: Andrejic, Olivera M., et al.
Publicado: (2019)

Variants Tagging LGALS-3 Haplotype Block in Association with First Myocardial Infarction and Plasma Galectin-3 Six Months after the Acute Event
por: Djordjevic, Ana, et al.
Publicado: (2022)

Association between Endothelial Cell-Specific Molecule 1 and Galectin-3 in Patients with ST-Segment Elevation Myocardial Infarction: A Pilot Study
por: Wei, Peng, et al.
Publicado: (2022)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction
por: Moon, In Tae, et al.
Publicado: (2021)

Early Treatment of Acute Myocardial Infarction with Melatonin: Effects on MMP-9 and Adverse Cardiac Events
por: Domínguez-Rodríguez, Alberto, et al.
Publicado: (2022)

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
por: Silverio, Angelo, et al.
Publicado: (2022)

Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
por: Yildiz, Mehmet, et al.
Publicado: (2023)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2022)

Myocardial infarction or myocarditis? A case report and review of a myocardial adverse event associated with mRNA vaccine
por: Badaró, Roberto, et al.
Publicado: (2023)

Trend of Galectin-3 Levels in Patients with Non-ST-Elevation and ST-Elevation Myocardial Infarction
por: Mitić, Branka, et al.
Publicado: (2022)

Macrophages secrete murinoglobulin-1 and galectin-3 to regulate neutrophil degranulation after myocardial infarction
por: Chalise, Upendra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dm4bv087d41shnq49tklb0eeig